High Tower Advisors, LLC Jazz Pharmaceuticals PLC Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, High Tower Advisors, LLC holds 7,594 shares of JAZZ stock, worth $933,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,594
Previous 5,534 37.22%
Holding current value
$933,834
Previous $590,000 43.39%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$100.57 - $116.37 $207,174 - $239,722
2,060 Added 37.22%
7,594 $846,000
Q2 2024

Aug 13, 2024
SELL
$103.94 - $118.98 $28,063 - $32,124
-270 Reduced 4.65%
5,534 $590,000
Q1 2024

May 06, 2024
BUY
$115.19 - $132.77 $74,527 - $85,902
647 Added 12.55%
5,804 $698,000
Q4 2023

Feb 12, 2024
SELL
$114.26 - $136.0 $19,995 - $23,800
-175 Reduced 3.28%
5,157 $634,000
Q3 2023

Nov 08, 2023
BUY
$122.0 - $145.31 $136,640 - $162,747
1,120 Added 26.59%
5,332 $690,000
Q2 2023

Aug 14, 2023
BUY
$122.5 - $147.16 $31,972 - $38,408
261 Added 6.61%
4,212 $522,000
Q1 2023

May 11, 2023
SELL
$133.98 - $160.47 $12,460 - $14,923
-93 Reduced 2.3%
3,951 $578,000
Q4 2022

Feb 08, 2023
BUY
$129.72 - $159.85 $280,584 - $345,755
2,163 Added 114.99%
4,044 $644,000
Q3 2022

Nov 09, 2022
BUY
$126.59 - $161.18 $253 - $322
2 Added 0.11%
1,881 $252,000
Q2 2022

Aug 10, 2022
BUY
$141.59 - $168.66 $15,999 - $19,058
113 Added 6.4%
1,879 $295,000
Q1 2022

May 12, 2022
SELL
$129.64 - $160.7 $67,542 - $83,724
-521 Reduced 22.78%
1,766 $276,000
Q4 2021

Feb 10, 2022
SELL
$119.87 - $145.67 $34,282 - $41,661
-286 Reduced 11.12%
2,287 $295,000
Q3 2021

Nov 12, 2021
SELL
$128.64 - $184.79 $7,461 - $10,717
-58 Reduced 2.2%
2,573 $339,000
Q2 2021

Aug 06, 2021
BUY
$160.2 - $186.42 $78,658 - $91,532
491 Added 22.94%
2,631 $465,000
Q1 2021

May 10, 2021
SELL
$150.19 - $173.5 $650,322 - $751,255
-4,330 Reduced 66.92%
2,140 $351,000
Q4 2020

Feb 10, 2021
SELL
$140.71 - $165.05 $1.04 Million - $1.22 Million
-7,420 Reduced 53.42%
6,470 $1.06 Million
Q3 2020

Nov 13, 2020
SELL
$105.46 - $144.13 $656,910 - $897,785
-6,229 Reduced 30.96%
13,890 $1.98 Million
Q2 2020

Aug 10, 2020
SELL
$95.68 - $121.88 $601,731 - $766,503
-6,289 Reduced 23.81%
20,119 $2.22 Million
Q1 2020

May 21, 2020
SELL
$87.74 - $152.74 $1.03 Million - $1.79 Million
-11,726 Reduced 30.75%
26,408 $2.63 Million
Q4 2019

Feb 14, 2020
BUY
$117.65 - $153.73 $759,195 - $992,019
6,453 Added 20.37%
38,134 $5.68 Million
Q3 2019

Nov 12, 2019
BUY
$125.18 - $143.24 $1.55 Million - $1.78 Million
12,397 Added 64.29%
31,681 $4.06 Million
Q2 2019

Aug 13, 2019
BUY
$125.55 - $144.48 $394,729 - $454,245
3,144 Added 19.48%
19,284 $2.75 Million
Q1 2019

May 15, 2019
BUY
$121.81 - $142.95 $187,709 - $220,285
1,541 Added 10.56%
16,140 $2.29 Million
Q4 2018

Feb 14, 2019
SELL
$115.94 - $166.74 $222,952 - $320,641
-1,923 Reduced 11.64%
14,599 $1.78 Million
Q3 2018

Nov 09, 2018
BUY
$161.01 - $180.57 $84,852 - $95,160
527 Added 3.29%
16,522 $2.75 Million
Q2 2018

Aug 14, 2018
BUY
$146.33 - $183.18 $618,683 - $774,485
4,228 Added 35.93%
15,995 $2.72 Million
Q1 2018

May 15, 2018
BUY
$135.59 - $157.16 $122,031 - $141,444
900 Added 8.28%
11,767 $1.81 Million
Q4 2017

Feb 14, 2018
SELL
$131.06 - $150.39 $159,631 - $183,175
-1,218 Reduced 10.08%
10,867 $1.47 Million
Q3 2017

Nov 14, 2017
BUY
$142.62 - $155.6 $739,342 - $806,630
5,184 Added 75.12%
12,085 $1.76 Million
Q2 2017

Aug 14, 2017
BUY
N/A
6,901
6,901 $1.08 Million

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email